Back to Newsroom

Catalyst Pharmaceuticals Announces Appointment of Richard J. Daly and Donald A. Denkhaus to Its Board of Directors

CORAL GABLES, Fla., Feb. 19, 2015 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), (Catalyst Pharmaceuticals), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced the appointment of Richard J. Daly and Donald A. Denkhaus to the Company’s Board of Directors.

Click here to read more